VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 10, 2010) - Tekmira Pharmaceuticals Corporation , a leader in RNA interference therapeutics, today provided an update on its internal product candidates and development plans. (10 mins ago)
↧